Overview

Phase 2, Double-blind, Randomized, Controlled Multi-center Clinical Trial of the Safety and Efficacy of Transplanted Fetal Porcine Cells in Patients With Parkinson's Disease.

Status:
Completed

Trial end date:
2001-01-01

Target enrollment:

Participant gender:

Summary

The purpose of this study was to evaluate the differences in safety and efficacy between Parkinson's disease patients who either received transplantation of fetal porcine cells or placebo treatment.

Phase:

Phase 2

Details

Lead Sponsor:

Genzyme, a Sanofi Company

Collaborator:

Diacrin/Genzyme Corporation LLC